Abstract
Immunological mechanisms play an important role in the pathogenesis of psoriasis. Lesional psoriatic skin-derived T-cell clones have been shown to stimulate keratinocyte proliferation and to predominantly express a T-helper type 1 cytokine pattern. However, T-helper type 2-like cytokines have also been identified in some psoriatic T-cell clones. In parallel to the T-helper type 1/type 2 dichotomy, a distinction between interferon-γ-induced (classically activated) macrophages and interleukin-4/glucocorticoid-induced (alternatively activated) macrophages has been put forward as a conceptual framework for a better understanding of immunopathological processes. In the present study, the phenotype of mononuclear phagocytes in psoriatic skin lesions (n=21), allergic contact dermatitis (n=4) and normal skin (n=2) was investigated using a panel of monoclonal antibodies (mAb) against monocytes/macrophages and dendritic cells (mAb MS-1, RM 3/1 and 25F9 against subsets of in vitro alternatively activated macrophages, and mAb against myeloid antigens CD1a, CD11b, CD11c, CD34, CD36, and CD68). With regard to mononuclear phagocytes, psoriatic skin was found to be compart-mentalized into epidermis, subepidermal space, and upper and lower dermis. RM 3/1+++, MS-1± 25F9− dendritic macrophages previously classified as type II alternatively activated macrophages were the dominant dermal macrophage population in psoriatic skin, while intraepidermal and epithelium-lining macrophages expressed a different, presumably classically activated, macrophage phenotype (RM 3/1−, MS-1−, 25F9−, CD68++, CD11b++). In allergic contact dermatitis a classical T-helper type 1 disease, RM 3/1+++ macrophages were less prominent. Since MS-1 high molecular weight protein is much more sensitive to interferon-γ-induced suppression than RM 3/1 antigen a predominance of T-helper type 1 cytokines in psoriasis could explain why dermal dendritic macrophages do not express the fully induced MS-1+++, RM 3/1+++, 25F9± phenotype of type I alternatively activated macrophages.
Similar content being viewed by others
References
Baker BS, Bokth S, Powles A, Garioch JJ, Lewis H, Valdimarsson H, Fry L (1993) Group A streptococcal antigen-specific T-lymphocytes in guttate psoriatic lesions. Br J Dermatol 128: 493–499
Barna M, Snijdewint FGM, Heijden FL, van der Bos JD, Kapsenberg ML (1994) Characterization of lesional psoriatic skin T lymphocyte clones. Acta Derm Venerol Suppl (Stockh) 186:9–11
Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD (1995) IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol 154: 1280–1286
Boehncke WH, Küenzlen C, Zollner TM, Mielke V, Sterry W (1994) Predominant usage of distinct T-cell receptor Vβ regions by epidermotropic T cells in psoriasis. Exp Dermatol 3: 161–163
Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J (1992) GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258–261
Caux C, Massacrier C, Vanbervliet B, Barthelemy C, Liu Y-J, Banchereau J (1994) Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol 6:1177–1185
Cowan HB, Vick S, Conary JT, Shepherd VL (1992) Dexamethasone upregulates mannose receptor activity by increasing mRNA levels. Arch Biochem Biophys 296:314–320
Dunham DM, Arkins S, Edwards CK, Dantzer R, Kelley KW (1990) Role of interferon-γ in counteracting the suppressive effects of transforming growth factor-β2 and glucocorticoids on the production of tumor necrosis factor-α. J Leukoc Biol 48: 473–481.
Elder IT, Nair RP, Guo S-W, Henseler T, Christophers E (1994) The genetics of psoriasis. Arch Dermatol 130: 216–224
Enk AH, Angeloni VL, Udey MC, Katz SI (1993) Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 151: 2390–2398
Gillitzer R, Wolff K, Tong D, Müller C, Yoshimura T, Hartmann AA, Stingl G, Berger R (1993) MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101: 127–131
Goerdt S, Steckel F, Schulze-Osthoff K, Hagemeier H-H, Macher E, Sorg C (1989) Characterization and differential expression of an endothelial cell-specific surface antigen in continuous and sinusoidal endothelia, in skin vascular lesions and in vitro. Exp Cell Biol 57: 185–192
Goerdt S, Walsh LJ, Murphy GF, Pober JS (1991) Identification of a novel high molecular weight protein antigen preferentially expressed by sinusoidal endothelial cells innormal human tissues. J Cell Biol 113: 1425–1437
Goerdt S, Bhardwaj R, Sorg C (1993) Inducible expression of MS-1 high molecular weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am J Pathol 142: 1409–1422
Griffiths CEM (1994) Cutaneous leukocyte trafficking and psoriasis. Arch Dermatol 130: 494–499
Hart PH, Ahern MJ, Jones CA, Jones KL, Smith MD, Finlay-Jones JJ (1993) Synovial fluid macrophages and blood monocytes differ in their response to IL-4. J Immunol 151: 3370–3380
Heng MCY, Kloss SG, Kuehn CS, Chase DG (1986) Significance and pathogenesis of basal keratinocyte herniations in psoriasis. J Invest Dermatol 87: 362–366
Heng MCY, Allen SG, Haberfelde G, Song MK (1991) Electron microscopic and immunocytochemical studies of the sequence of events in psoriatic plaque formation following tape stripping. Br J Dermatol 125: 548–556
Kodelja V, Goerdt S (1994) Dissection of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro. Exp Dermatol 3: 257–268
Kristensen M, Deleuran B, Eedy DJ, Feldman M, Breathnach SM, Brennan FM (1992) Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1α in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis. Br J Dermatol 127: 305–311
Lewis HM, Baker BS, Bokth S, Powles AV, Garioch JJ, Valdimarsson H, Fry L (1993) Restricted T-cell receptor Vβ gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 129: 514–520
Liew FY, Li Y, Severn A, Millott S, Schmidt J, Salter M, Moncada S (1991) A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur J Immunol 21: 2489–2494
Manetti R, Parronchi P, Giudizi MG, Piccini MP, Maggi E, Trinchieri G, Romagnani S (1993) Natural killer cell stimulatory factor (interleukin-12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177: 1199–1204
Marianayagam L, Poulter LW (1991) Corticosteroid can alter antigen expression on alveolar macrophages. Clin Exp Immunol 85: 531–535
McKenzie ANJ, Culpepper JA, Waal Malefyt R de, Briere F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BG, Menon S, Vries JE de, Banchereau J, Zurawski G (1993) Interleukin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 90: 3735–3739
Minty A, Chalon P, Derocq JM, Dumont X, Guilemot J-C, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D (1993) Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248–250
Montaner LJ, Doyle AG, Collin M, Herbein G, Illei P, James W, Minty A, Caput D, Ferrara P, Gordon S (1993) Interleukin-13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J Exp Med 178: 743–747
Nestle FO, Turka LA, Nickoloff BJ (1994) Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphcytes and induction of TH1 type cytokines. J Clin Invest 94: 202–209
Oord van den JJ, Wolf-Peeters C de (1994) Epithelium-lining macrophages in psoriasis. Br J Dermatol 130: 589–594
Paukkonen K, Naukkarinen A, Horsmanheimo M (1992) The development of manifest psoriatic lesions is linked with the invasion of CD8+ T cells and CD11c+ macrophages into the epidermis. Arch Dermatol Res 284: 375–379
Pigatto PD, Pigatto LB, Bigardi A, Altomare G, Finzi AF (1990) Factors secreted by untreated psoriatic monocytes enhance neutrophil function. J Invest Dermatol 94: 372–376
Prens EP, Benne K, Joost T van, Benner R (1991) The autologous mixed epidermal cell T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a-antigen-presenting cells. J Invest Dermatol 96: 880–887
Prinz JC, Gross B, Vollmer S, Trommler P, Strobel I, Meurer M, Plewig G (1994) T cell clones from psoriasis skin lesions can promote kereatinocyte proliferation in vitro via secreted products. Eur J Immunol 24: 593–598
Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, Waal Malefyt R de, Vries JE de (1993) Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 90: 3730–3734
Rein G, Abraham A, Raychadauri SP, Weltman H (1994) Monocyte adhesion to fibronectin in psoriasis. Int J Dermatol 33: 374–379
Rieger-Wettengl G, Castellucci M, Schulze H-J (1994) Subepidermal macrophages—a diagnostic marker for psoriasis versus psoriasiform dermatitis (abstract). Arch Dermatol Res 286: 207
Sallusto F, Cella M, Danieli C, Lanzavecchia A (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182: 389–400
Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE (1992) TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol 52: 274–281
Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, Meyer zum Büschenfelde K-H, Fleischer B (1994) T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102: 145–149
Schmitt-Egenolf M, Boehncke W-H, Ständer M, Eiermann TH, Sterry W (1993) Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB1*0701/2, −DQ1*0201, −DQB1*0303 extended haplotype. J Invest Dermatol 100: 749–752
Schopf RE, Dobmeyer J, Dobmeyer T, Morsches B (1993) Soluble CD14 monocyte antigen in suction blister fluid and serum of patients with psoriasis. Dermatology 186: 45–49
Schubert C, Christophers E (1985) Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res 277: 352–358
Scott P (1993) IL-12: initiation cytokine for cell-mediated immunity. Science 260: 496–497
Spiteri MA, Poulter LW (1991) Characterization of immune inducer and suppressor macrophages from the normal human lung. Clin Exp Immunol 83: 157–162
Spiteri MA, Clarke SW, Poulter LW (1988) Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol 74: 359–364
Stein M, Keshav S, Harris N, Gordon S (1992) Interleukin-4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287–292
Sterry W, Boehnke W-H (1993) Phenotypic heterogeneity of the dermal monocyte/macrophage system. In: Nickoloff BJ (ed) Dermal immune system. CRC Press, Boca Raton, pp 67–89
Stingl G, Bergstresser PR (1995) Dendritic cells: a major story unfolds. Immunol Today 16: 330–333
Strange P, Cooper KD, Hansen ER, Fisher G, Larsen JK, Fox D, Krag C, Voorhees JJ, Baadsgaard O (1993) T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinoyte proliferation. J Invest Dermatol 101: 695–700
Tanaka M, Lee K, Yodoi J, Saito H, Iwai Y, Kim K-M, Morita M, Mayumi M, Mikawa H (1989) Regulation of FcεRII (CD23) expression on a human eosinophilic cell line EoL3 and a human monocytic cell line U937. Cell Immunol 122: 96–107
Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A, Bowcock A (1994) Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264: 1141–1145
Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ (1993) The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 101: 701–705
Villanueva POF, Harris TS, Ricklan DE, Stadecker MJ (1994) Macrophages from schistosomal egg granulomas induce unresponsiveness in specific cloned Th-1 lymphocytes in vitro and down-regulate schistosomal granulomatous disease in vivo. J Immunol 152: 1847–1855
Villanueva POF, Reiser H, Stadecker MJ (1994) Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. J Immunol 153: 5190–5199
Vollmor S, Menssen A, Trommler P, Schendel D, Prinz JC (1994) T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 24: 2377–2382
Waal Malefyt R de, Haanen J, Spits H, Roncarolo M-G, Velde A te, Figdor C, Johnson K, Kastelein R, Yssel H, Vries JE de (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174: 915–924
Walsh LJ, Goerdt S, Pober JS, Sueki H, Murphy GF (1991) MS-1 sinusoidal endothelial antigen is expressed by factor XIIIa+, HLA-DR+ dermal perivascular dendritic cells. Lab Invest 65: 732–741
Weber-Matthiesen K, Sterry W (1990) Organisation of the monocyte/macrophage system of normal human skin. J Invest Dermatol 95: 83–89
Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ (1988) Transforming growth factor-β is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 157: 793–800
Wölfer L-U, Djemadji-Oudjiel N, Hiletework M, Tebbe B, Husak R, Goerdt S, Orfanos CE (1996) HIV-assoziierte Psoriasis. Klinische und histologische Beobachtungen an 36 Patientten. Hautzartz (in press)
Wölfer L-U, Goerdt S, Schröder K, Zouboulis CC, Orfanos E (1996) Interferon-γ-induzierte Psoriasis. Hautarzt 47: 124–128
Zlotnik A, Moore KW (1992) Interleukin 10. Cytokine 3: 366–371
Zurawski SM, Vega F Jr, Huyghe B, Zurawski G (1993) Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 12: 2663–2670
Zwadlo G, Bröcker EB, Bassewitz D-B von, Feige U, Sorg C (1985) A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol 134: 1487–1492
Zwadlo G, Voegeli R, Schulze-Osthoff K, Sorg C (1987) A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol 55: 295–304
Zwadlo-Klarwasser G, Bent S, Haubeck H-D, Sorg C, Schmutzler W (1990) Glucocorticoid-induced appearance of the macrophage subtype RM 3/1 in peripheral blood in man. Int Arch Allergy Appl Immunol 91: 175–180
Zwadlo-Klarwasser G, Bent S, Schmutzler W (1991) Comparison of dermal and systemic application of glucocorticoids on the RM 3/1+ macrophages in human blood. Int Arch Allergy Appl Immunol 94: 278–279
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Djemadji-Oudjiel, N., Goerdt, S., Kodelja, V. et al. Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+++, MS-1± 25F9−) in psoriatic dermis. Arch Dermatol Res 288, 757–764 (1996). https://doi.org/10.1007/BF02505293
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02505293